Nanomedicine Technologies for Diagnosis and Treatment of Breast Cancer

被引:12
|
作者
Kitsios, Katerina [1 ,2 ]
Sharifi, Shahriar [1 ,2 ]
Mahmoudi, Morteza [1 ,2 ]
机构
[1] Michigan State Univ, Dept Radiol, E Lansing, MI 48824 USA
[2] Michigan State Univ, Precis Hlth Program, E Lansing, MI 48824 USA
关键词
breast cancer; nanomedicine; drug delivery; diagnosis; treatment; POLYMERIC MICELLE FORMULATION; INVASIVE DUCTAL CARCINOMA; PHASE-II TRIAL; TARGETED THERAPY; CREMOPHOR-FREE; GENEXOL-PM; NANOPARTICLES; DELIVERY; METASTASIS; STATISTICS;
D O I
10.1021/acsptsci.3c00044
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Breast cancer is one of the most common cancers in women worldwide, yet conventional treatments have several shortcomings, including low specificity, systemic toxicity, and drug resistance. Nanomedicine technologies provide a promising alternative while also overcoming the limitations posed by conventional therapies. This mini-Review highlights important signaling pathways related to occurrence and development of breast cancer and current breast cancer therapies, followed by an analysis of various nanomedicine technologies developed for diagnosis and treatment of breast cancers.
引用
收藏
页码:671 / 682
页数:12
相关论文
共 50 条
  • [1] Nanomedicine: a frontier of the breast cancer treatment
    Sonar, Swarup
    Nyahatkar, Sidhanti
    Kalele, Ketki
    Adhikari, Manab Deb
    [J]. CLINICAL AND TRANSLATIONAL DISCOVERY, 2024, 4 (02):
  • [2] Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies
    Nounou, Mohamed I.
    ElAmrawy, Fatema
    Ahmed, Nada
    Abdelraouf, Kamilia
    Goda, Satyanarayana
    Syed-Sha-Qhattal, Hussaini
    [J]. BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2015, 9 : 17 - 34
  • [3] The development and progress of nanomedicine for esophageal cancer diagnosis and treatment
    Li, Xiaokun
    Chen, Lingmin
    Luan, Siyuan
    Zhou, Jianfeng
    Xiao, Xin
    Yang, Yushang
    Mao, Chengyi
    Fang, Pinhao
    Chen, Longqi
    Zeng, Xiaoxi
    Gao, Huile
    Yuan, Yong
    [J]. SEMINARS IN CANCER BIOLOGY, 2022, 86 : 873 - 885
  • [4] Nanomedicine for the treatment of triple-negative breast cancer
    Kutty, Rajaletchumy Veloo
    Leong, David Tai Wei
    Feng, Si-Shen
    [J]. NANOMEDICINE, 2014, 9 (05) : 561 - 564
  • [5] Insights into Nanomedicine for Head and Neck Cancer Diagnosis and Treatment
    Viegas, Claudia
    Pereira, Daniela S. M.
    Fonte, Pedro
    [J]. MATERIALS, 2022, 15 (06)
  • [6] The development and progress of nanomedicine for esophageal cancer diagnosis and treatment
    Li, Xiaokun
    Chen, Lingmin
    Luan, Siyuan
    Zhou, Jianfeng
    Xiao, Xin
    Yang, Yushang
    Mao, Chengyi
    Fang, Pinhao
    Chen, Longqi
    Zeng, Xiaoxi
    Gao, Huile
    Yuan, Yong
    [J]. SEMINARS IN CANCER BIOLOGY, 2022, 86 : 873 - 885
  • [7] The development and progress of nanomedicine for esophageal cancer diagnosis and treatment
    Li, Xiaokun
    Chen, Lingmin
    Luan, Siyuan
    Zhou, Jianfeng
    Xiao, Xin
    Yang, Yushang
    Mao, Chengyi
    Fang, Pinhao
    Chen, Longqi
    Zeng, Xiaoxi
    Gao, Huile
    Yuan, Yong
    [J]. SEMINARS IN CANCER BIOLOGY, 2022, 86 : 873 - 885
  • [8] Current progress of nanomedicine for prostate cancer diagnosis and treatment
    Zhao, Jiang
    Zhang, Chi
    Wang, Weihao
    Li, Chen
    Mu, Xupeng
    Hu, Kebang
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 155
  • [9] Multifunctional polymeric micellar nanomedicine in the diagnosis and treatment of cancer
    Raval, Nidhi
    Maheshwari, Rahul
    Shukla, Havish
    Kalia, Kiran
    Torchilin, Vladimir P.
    Tekade, Rakesh K.
    [J]. MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2021, 126
  • [10] Nanomedicine in treatment of breast cancer ? A challenge to conventional therapy
    Afzal, Muhammad
    Ameeduzzafar
    Alharbi, Khalid Saad
    Alruwaili, Nabil K.
    Al-Abassi, Fahad A.
    Al-Malki, Abdulrahman Al Labeed
    Kazmi, Imran
    Kumar, Vikas
    Kamal, Mohammad Amjad
    Nadeem, Muhammad Shahid
    Aslam, Muhammad
    Anwar, Firoz
    [J]. SEMINARS IN CANCER BIOLOGY, 2021, 69 : 279 - 292